BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8995415)

  • 1. Apurinic sites are position-specific topoisomerase II poisons.
    Kingma PS; Osheroff N
    J Biol Chem; 1997 Jan; 272(2):1148-55. PubMed ID: 8995415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA abasic lesions in a different light: solution structure of an endogenous topoisomerase II poison.
    Cline SD; Jones WR; Stone MP; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15500-7. PubMed ID: 10569932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.
    Kingma PS; Greider CA; Osheroff N
    Biochemistry; 1997 May; 36(20):5934-9. PubMed ID: 9166762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
    Kingma PS; Corbett AH; Burcham PC; Marnett LJ; Osheroff N
    J Biol Chem; 1995 Sep; 270(37):21441-4. PubMed ID: 7665552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous DNA damage stimulates topoisomerase II-mediated DNA cleavage.
    Kingma PS; Osheroff N
    J Biol Chem; 1997 Mar; 272(11):7488-93. PubMed ID: 9054451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Base excision repair intermediates as topoisomerase II poisons.
    Wilstermann AM; Osheroff N
    J Biol Chem; 2001 Dec; 276(49):46290-6. PubMed ID: 11591703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions.
    Sabourin M; Osheroff N
    Nucleic Acids Res; 2000 May; 28(9):1947-54. PubMed ID: 10756196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
    Bender RP; Osheroff N
    Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
    Borgnetto ME; Tinelli S; Carminati L; Capranico G
    J Mol Biol; 1999 Jan; 285(2):545-54. PubMed ID: 9878428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase II-mediated DNA cleavage: evidence for distinct regions of enzyme-DNA contacts.
    Alsner J; Sorensen HV; Schmidt VK; Sorensen BS; Westergaard O
    J Mol Biol; 1996 Jun; 259(3):317-24. PubMed ID: 8676370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
    VĂ©lez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
    Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicative helicases can translocate through abasic site-induced covalent topoisomerase IV-DNA complexes.
    Shea ME; Hiasa H
    Nucleic Acids Res; 2001 Feb; 29(3):614-21. PubMed ID: 11160881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of topoisomerase II-mediated DNA cleavage in the 5'-region of the Drosophila hsp70 gene. Identification of a novel half-site DNA substrate for topoisomerase II cleavage.
    Kroeger PE; Osheroff N; Rowe TC
    J Biol Chem; 1993 Aug; 268(22):16449-57. PubMed ID: 8393863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
    Dickey JS; Osheroff N
    Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2-Naphthoquinone as a Poison of Human Type II Topoisomerases.
    Collins JA; Osheroff N
    Chem Res Toxicol; 2021 Apr; 34(4):1082-1090. PubMed ID: 33760604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
    Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
    Wilstermann AM; Osheroff N
    Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.